Trial Profile
An Open-Label Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile in Plasma and Epithelial Lining Fluid of Finafloxacin After Single and Multiple Doses Administered Orally in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Feb 2017
Price :
$35
*
At a glance
- Drugs Finafloxacin (Primary)
- Indications Bacterial infections; Respiratory tract infections
- Focus Adverse reactions
- 02 Aug 2013 New trial record